Teva Pharmaceutical Industries Ltd ADR
TEVA: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$44.00 | Rfm | Mnjmpcxc |
Placing Teva Under Review
We are placing Teva under review as we evaluate analyst stock coverage decisions. As a reminder, we provide broad coverage of close to 1,500 companies globally and periodically adjust our coverage according to investor interest and staffing.